These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 4707699)

  • 1. Serum LH concentration in women under contraceptive treatment with estrogen-free progestagens.
    Garmendia F; Kesserü E; Llerena LA
    Horm Metab Res; 1973 Mar; 5(2):134-8. PubMed ID: 4707699
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of human luteinizing hormone in plasma by radioimmunoassay.
    Schalch DS; Parlow AF; Boon RC; Reichlin S
    J Clin Invest; 1968 Mar; 47(3):665-78. PubMed ID: 4295312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of exogenous estrogen and progestin on pituitary responsiveness to synthetic luteinizing hormone-releasing factor.
    Vandenberg G; DeVane G; Yen SS
    J Clin Invest; 1974 Jun; 53(6):1750-4. PubMed ID: 4598115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting serum growth hormone levels and growth hormone responses to exercise during normal menstrual cycles and cycles of oral contraceptives.
    Hansen AP; Weeke J
    Scand J Clin Lab Invest; 1974 Nov; 34(3):199-205. PubMed ID: 4428162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radioimmunologic studies on serum gonadotropic hormones during oral contraception].
    Carol W; Lauterbach H; Klinger G; Stoll W; Hempel E; Chemnitius KH
    Zentralbl Gynakol; 1975; 97(24):1518-26. PubMed ID: 1227210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Restoration of pituitary-ovarian function after long-term application of combined norethindrone oenanthate].
    Shen KY
    Zhonghua Fu Chan Ke Za Zhi; 1988 Sep; 23(5):293-5, 318. PubMed ID: 3150744
    [No Abstract]   [Full Text] [Related]  

  • 8. Pituitary and hypothalamic action of progestagens in castrated female rats.
    Bieglmayer C; Spona J; Schroeder R
    Endocrinol Exp; 1980 Mar; 14(1):17-25. PubMed ID: 6772424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of partial components of a contraceptive agent on the function of the menstrual cycle].
    Schneider W; Spona J; Matt K
    Med Klin; 1973 Apr; 68(16):510-5. PubMed ID: 4707381
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of a contraceptive agent on the function of the peripheral and central menstrual cycle].
    Spona J; Schneider W; Matt K
    Med Klin; 1973 Apr; 68(16):505-9. PubMed ID: 4707380
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppressive action of norethisterone enanthate and acetate on gonadotropin. (FSH and LH) levels. Radioimmunoassay in eugonadal and postmenopausal women.
    Franchimont P; Cession G; Ayalon D; Mutsers A; Legros JJ
    Obstet Gynecol; 1970 Jul; 36(1):93-100. PubMed ID: 5422095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Testing of the steroid-related suppressive effect on the hypothalamo-hypophyseal system using twofold stimulation].
    Carol W; Lauterbach H; Klinger G
    Zentralbl Gynakol; 1984; 106(6):359-67. PubMed ID: 6426199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a synthetic estrogen-progestogen agent on urinary gonadotropin levels of FSA and LH using a radioimmunologic method.
    Forleo R; Vegna G; Pala A
    Acta Eur Fertil; 1972 Jun; 3(2):159-76. PubMed ID: 4679575
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
    Hendrix CW; Jackson KA; Whitmore E; Guidos A; Kretzer R; Liss CM; Shah LP; Khoo KC; McLane J; Trapnell CB
    Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with implant contraception.
    Coutinho E
    Contraception; 1978 Oct; 18(4):411-27. PubMed ID: 720074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of Premarin and norgestrel on plasma FSH, LH and androstenedione in post-menopausal women.
    Sexton L; Anderton KJ; Lenton EA; Brooke LM; Cooke ID
    Postgrad Med J; 1978; 54 Suppl 2():42-6. PubMed ID: 216981
    [No Abstract]   [Full Text] [Related]  

  • 17. Gonadotropin responses following luteinizing hormone releasing hormone administration in normal subjects.
    Wentz AC; Jones GS; Rocco L
    Obstet Gynecol; 1975 Mar; 45(3):239-46. PubMed ID: 1089927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunosorbent assay of follicle-stimulating hormone and luteinizing hormone in serum and urine from men and women.
    Wide L; Nillius SJ; Gemzell C; Roos P
    Acta Endocrinol Suppl (Copenh); 1973; 174():3-58. PubMed ID: 4542207
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of synthetic FSH-LH/RH on plasma FSH, LH and 17beta-estradiol in women under oral steroid contraception.
    Neves-e-Castro M; Lucio A; Silva LA; Reis-Valle A
    Reproduccion; 1974; 1(4):393-400. PubMed ID: 4619379
    [No Abstract]   [Full Text] [Related]  

  • 20. Augmentative and inhibitory effects of chronic steroid injections on LH release and their dependency on time.
    Kuhl H; Baziad A; Taubert HD
    Endocrinol Exp; 1982 Jun; 16(2):93-101. PubMed ID: 7049671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.